Skip to Content
Stock Strategist Industry Reports

Our 'Buy American' Moment Has Arrived for U.S. Multi-Industrials

The discounts we see now are several and sometimes compelling.

Mentioned: , , , , , , , , ,

Today, we remind investors of what Ben Graham wrote about Mr. Market in The Intelligent Investor 70 years ago: “Every day he tells you what he thinks your interest is worth and furthermore offers either to buy you out or sell you an additional interest on that basis. Sometimes his idea of value appears plausible and justified by business developments and prospects as you know them. Often, on the other hand, Mr. Market lets his enthusiasm or his fears run away with him, and the value he proposes seems to you a little short of silly.” Just a few months ago, we believed greed was taking hold of Mr. Market, as our diversified coverage was split 57/43 in favor of 3-star and 2-star-rated stocks. We had no multi-industrial stock ideas.

Now, fear has spread to even tenured investors regarding the long-term implications of the coronavirus outbreak, which has had a larger impact than almost any expert predicted early on, and by all accounts is likely to remain with us for some time to come. But as was true when Warren Buffett wrote his "Buy American" New York Times op-ed in 2008, fears regarding the long-term prosperity of moaty companies make little sense when measured from our bottom-up, long-term assessment of the fundamentals of these stalwarts of American industry. That’s not a blank endorsement of every U.S. multi-industrial we cover; there are names that we still don’t believe merit a place in an investor’s portfolio at today’s prices. Nevertheless, while we could be early, and intrinsic value is hardly immutable, we think we find multiple decent and even some compelling discounts at today’s prices. Keep in mind that for companies protected by a moat (the wider, the better), the lion’s share of our assessed value lies in stages two and three of our valuation. Even assuming the coronavirus pandemic is a two-year disruption, buying the stocks of companies protected by a moat should provide downside protection for investors.

Joshua Aguilar does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.